Sara Picó

Sara Picó currently serves as an Analyst at Debiopharm, operating within the specialized biotechnology investment sector to identify promising global life sciences opportunities. In this specific capacity, she evaluates early-stage ventures and actively supports innovation funding initiatives designed to advance novel therapeutic developments and medical technologies. Operating within the broader biopharmaceutical industry, Picó conducts rigorous market research, scientific due diligence, and financial modeling to identify emerging startups seeking critical capital for preclinical and clinical research phases. Her daily responsibilities involve analyzing complex scientific data, assessing long-term commercial viability, and monitoring macroeconomic trends across the global healthcare landscape to guide strategic capital allocation for the investment firm. Ultimately, Picó maintains a primary professional focus on bridging the critical gap between early-stage scientific discovery and market commercialization by facilitating essential financial backing for next-generation biotechnology startup enterprises.